Researchers, including those at the University of North Carolina, US, found that the oral form of Semaglutide can ...

Semaglutide can help lower the risk of cardiovascular complications in people with diabetes, a new study has found.

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed ... pill's approval to include lowering the risk of serious cardiovascular complications, Stephen Gough, the company's global ...

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

A GLP-1 oral medication claims to cut the risk of cardiovascular complications, like heart attacks and strokes, by 14% for people with diabetes and heart or kidney disease, per CNBC.